ReviewHematology. American Society of Hematology. Education Program2023

Considerations for next therapy after anti-CD38 monoclonal antibodies used as first line.

Monique Hartley-Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.